NLRP3 and metabolic dysfunction-associated steatotic liver disease: Hepatic steatosis (MASLD) is associated with enhanced NLRP3 inflammasome activation, mitochondrial dysfunction, and secretion of pro-inflammatory chemokines by hepatocytes and infiltrating immune cells [131].